NA
PFE icon

Nordwand Advisors’s Pfizer PFE Stock Holding History

Nordwand Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-250
Closed -$6.33K – 203
2025
Q1 		$6.33K Hold
250
– – ﹤0.01% 87
2024
Q4 		$6.63K Hold
250
– – ﹤0.01% 96
2024
Q3 		$7.24K Hold
250
– – ﹤0.01% 95
2024
Q2 		$7K Sell
250
-200
-44% -$5.51K ﹤0.01% 116
2024
Q1 		$12.5K Buy
450
+250
+125% +$6.94K ﹤0.01% 119
2023
Q4 		$5.76K Hold
200
– – ﹤0.01% 132
2023
Q3 		$6.63K Buy
+200
New +$7.07K ﹤0.01% 104
2023
Q2 		– Sell
-44,709
Closed -$1.82M – 128
2023
Q1 		$1.82M Sell
44,709
-55,195
-55% -$2.38M 0.3% 24
2022
Q4 		$5.12M Buy
+99,904
New +$4.79M 0.64% 21

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Nordwand Advisors's PFE Position: Q2 2025 in Review

Nordwand Advisors sold out of Pfizer (PFE) in Q2 2025, closing a stake of 250 shares — an estimated $6.33K sold.

Nordwand Advisors first reported a position in PFE in Q4 2022 and held it in 9 quarters. The position peaked at $5.12M in Q4 2022. 2,813 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

  • Nordwand Advisors reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
  • Nordwand Advisors sold 250 Pfizer shares in Q2 2025, an estimated $6.33K.
  • Nordwand Advisors first reported a position in Pfizer in Q4 2022 and held it in 9 quarters.
  • Nordwand Advisors's Pfizer position peaked at $5.12M in Q4 2022.
  • 2,813 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on Nordwand Advisors's 13F filing for Q2 2025, filed 11 Aug 2025.